The Conference
A Celebration of 3D Biology
03 December 2020
Program APAC:
16:00 - 17:45 JST
Program EU / US:
15:00 - 17:30 CET / 9-11:30am EST
To put new developments in 3D tissue biology in the limelight, MIMETAS organizes 3D-cember, a global live-streamed event on December 3, 2020.
3D tissue culture technologies and systems have come a long way over the last ten years. More and more scientists and physicians are embracing it. They want to tap into the enormous potential of 3D tissue culture for drug development, patient care, and fundamental science. Still, there’s a lot ahead of us with new biological applications and rapid technological innovations.
3D-cember: Live! In Your Living Room
After the success of last year’s – in-person – edition of 3D-cember in Amsterdam, Boston, and Tokyo
we are continuing it this year as a digital event! We’re embracing the fact that distance is no longer a barrier to enjoying great science these days and have put together a wonderful live-streamed global program for you.
One Event, Two Live-Streamed International Scientific Programs
On Thursday, December 3rd, 2020, we will kick-off the digital event with a live-streamed program
for APAC (JST time zone), to further continue with a second live-streamed program for EU & US (CET & EST time zone).
From the comfort of your home, office, or lab, you will be able to enjoy an inspiring scientific program
that covers 3D tissue culture from a broad perspective, involving international key opinion leaders from pharma, biotech, and academia.
Why should you join?
Join us at this exciting event to:
• Learn about the latest science and developments from key opinion leaders
across the globe
• See the latest products and technologies for your research
• Get in touch with peers and thought leaders through the virtual event platform
and interactive breakout sessions
Last year's numbers
Participants
210
Speakers
9
Locations
3
Speakers
-
Kazuhiro Tetsuka, PhD
Astellas Pharma Inc.
-
Professor Takanori Takebe
Cincinnati Children's Hospital Medical Center /
Tokyo Medical and Dental University
-
Michael Bscheider, MD
Pharmaceutical Sciences (PS) / Investigative Safety, Roche
-
Professor Jeroen Pasterkamp
Professor of Translational Neuroscience, UMC Utrecht
-
Olive Jung
National Center for Advancing Translational Sciences (NCATS)
-
Sakshi Garg, PhD
Head of Laboratory 3D cell culture & HTS, Merck Group
-
Martin Verhoef
VP Innovation Danaher Life Sciences Instruments Group, Danaher
Sponsored by
